Novo Nordisk to seek regulatory approval for Wegovy pill in China soon, says CEO
BEIJING - Novo Nordisk plans to seek Chinese regulatory approval for its weight-loss pill "very soon," CEO Mike Doustdar said Tuesday, in a move to catch up with rival Eli Lilly in the world's second-largest pharmaceutical market.
(Reporting by Andrew Silver; Editing by Christopher Cushing)
Copyright Reuters or USA Today Network via Reuters Connect
This story was originally published June 16, 2026 at 2:02 AM.